Loading clinical trials...
Loading clinical trials...
The Comparison of Microneedling Therapy With or Without Amnion Bilayer Sheeting on Post-Burn Hypertrophic Scar Tissue
The aim of this study is to compare the outcome of microneedling therapy with or without amnion bilayer sheeting on post-burn hypertrophic scar tissue. A clinical trial will be conducted with 17 samples, from September to December 2021.
High degree burn injuries commonly result in abnormal scar formation, and therapy for this hypertrophic scar remains a challenge. For years, microoneedling has been used for treating hypertrophic scars, and an addition of amnion bilayer sheeting is expected to provide a more favorable outcome. This study aims to compare microneedling therapy with or without amnion bilayer sheeting on post-burn hypertrophic scars tissue. This is an interventional study with 17 samples, aged 18-50 years old. Therapeutic outcomes will be evaluated using visual analog scale, degree of erythema, patient's subjective evaluation, dermoscope, biopsy, and skin ultrasound.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
dr. Cipto Mangunkusumo Hospital
Jakarta, Jakarta Pusat, Indonesia
Start Date
September 1, 2021
Primary Completion Date
December 30, 2021
Completion Date
January 31, 2022
Last Updated
August 6, 2021
17
ESTIMATED participants
Microoneedling and Amnion Bilayer
PROCEDURE
Microoneedling
PROCEDURE
Lead Sponsor
Dr.dr.Irma Bernadette, SpKK (K)
NCT06801626
NCT06806735
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions